Avanos Medical Set to Showcase Innovation at Prestigious J.P. Morgan Healthcare Conference
Alpharetta, Georgia – January 7, 2026 – Avanos Medical, Inc. (NYSE: AVNS), a dynamic player in the medical technology landscape, announced today that Chief Executive Officer Dave Pacitti is slated to present at the highly anticipated 44th Annual J.P. Morgan Healthcare Conference. The event, a cornerstone for industry leaders and investors, will take place in San Francisco, California, with Pacitti’s address scheduled for Tuesday, January 13th, at approximately 2:15 p.m. PST.
This presentation offers a significant platform for Avanos Medical to articulate its strategic vision and highlight its contributions to advancing patient care. The company’s focus on delivering clinically superior medical device solutions is designed to empower patients to regain their mobility and return to fulfilling lives. Key areas of innovation for Avanos include critical support for nutritional needs, bridging the gap from hospital to home, and pioneering approaches to reduce opioid reliance while facilitating smoother patient recovery post-surgery.
Avanos Medical has established a strong global presence, developing, manufacturing, and marketing a portfolio of recognized brands that hold leading market positions across various healthcare segments. The company’s commitment to addressing pressing healthcare challenges underscores its role as an innovator in the medtech sector.
Investors and interested parties can access a webcast of the conference presentation via the Investors section on the Avanos Medical website. The webcast will remain archived on the site for subsequent viewing, providing valuable insights into the company’s performance and future outlook.
The J.P. Morgan Healthcare Conference serves as a critical juncture for companies like Avanos Medical to engage with the financial community, share technological advancements, and discuss market trends. For Avanos, the opportunity to present amidst a backdrop of significant industry discourse is expected to generate valuable engagement and potentially illuminate the company’s growth trajectory and its impact on the evolving healthcare ecosystem. The company’s dual focus on patient recovery and nutritional support places it at the intersection of significant demographic and healthcare spending trends, including an aging population and a growing demand for home-based care solutions.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/15447.html
